Table 2. Baseline characteristics of patients with and without AF during hospitalization.
| With AF | Without AF | ||
|---|---|---|---|
| (n = 78) | (n = 646) | p | |
| Age (years) | 71.7 ± 10.0 | 66.7 ± 12.2 | 0.001 |
| Male | 66 (84.6) | 516 (79.9) | 0.319 |
| Hypertension | 54 (69.2) | 410 (63.5) | 0.316 |
| Diabetes mellitus | 31 (39.7) | 234 (36.2) | 0.542 |
| Renal insufficiency | 16 (20.5) | 117 (18.1) | 0.605 |
| Previous PCI | 13 (16.7) | 63 (9.8) | 0.060 |
| Previous CABG | 5 (6.4) | 26 (4.0) | 0.367 |
| Previous MI | 13 (16.7) | 66 (10.2) | 0.084 |
| Previous stroke/TIA | 14 (17.9) | 74 (11.5) | 0.098 |
| Previous heart failure | 7 (9.0) | 36 (5.6) | 0.211 |
| Left atrial diameter (mm) | 42.7 ± 8.3 | 39.3 ± 6.0 | 0.014 |
| LVEF (%) | 38.6 ± 15.2 | 44.6 ± 13.4 | 0.004 |
| Killip classification |
<0.001 | ||
| Killip = 1 | 27 (34.6) | 380 (58.9) | |
| Killip > 1 | 51 (65.4) | 265 (41.1) | |
| Medication use at index admission |
|||
| β-blocker | 33 (42.3) | 348 (53.9) | 0.053 |
| ACE inhibitor | 31 (39.7) | 401 (62.1) | <0.001 |
| Calcium channel blocker | 17 (21.8) | 179 (27.7) | 0.267 |
| Statin | 12 (15.4) | 261 (40.4) | <0.001 |
| CRP (mg/dl) | 1.52 ± 2.16 | 0.94 ± 1.42 | 0.043 |
| CHADS2 score | 2.05 ± 1.38 | 1.61 ± 1.26 | 0.004 |
Values are mean ± SD or number (%).
MI: myocardial infarction; PCI: percutaneous coronary intervention; CABG: coronary artery bypass grafting; TIA: transient ischemic attack; LVEF: left ventricular ejection fraction; ACE: angiotensin-converting enzyme; A II: angiotensin II; CRP: C-reactive protein